Eventide Asset Management - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 81 filers reported holding SUTRO BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2022$15,035,000
+6.5%
2,708,9750.0%0.30%
-2.0%
Q2 2022$14,114,000
-36.6%
2,708,9750.0%0.30%
-13.5%
Q1 2022$22,268,000
-44.8%
2,708,9750.0%0.35%
-32.2%
Q4 2021$40,310,000
-10.0%
2,708,975
+14.3%
0.52%
-12.9%
Q3 2021$44,788,000
+1.6%
2,370,9750.0%0.59%
-0.2%
Q2 2021$44,076,000
-18.3%
2,370,9750.0%0.59%
-26.0%
Q1 2021$53,963,000
+4.8%
2,370,9750.0%0.80%
+1.4%
Q4 2020$51,474,000
+157.9%
2,370,975
+19.4%
0.79%
+101.8%
Q3 2020$19,959,000
+29.5%
1,985,9750.0%0.39%
+16.7%
Q2 2020$15,411,000
+17.5%
1,985,975
+54.4%
0.34%
-21.2%
Q1 2020$13,117,000
-4.2%
1,285,975
+3.3%
0.42%
+10.1%
Q4 2019$13,694,000
+187.0%
1,244,895
+137.1%
0.39%
+144.3%
Q3 2019$4,772,000
-65.3%
525,000
-57.8%
0.16%
-62.2%
Q2 2019$13,758,000
-0.1%
1,244,8950.0%0.42%
-11.8%
Q1 2019$13,770,000
+26.3%
1,244,8950.0%0.47%
-1.9%
Q4 2018$10,904,000
-39.9%
1,244,8950.0%0.48%
-27.5%
Q3 2018$18,134,0001,244,8950.67%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders